Chagas
Diretrizes
5. Expert consensus document on management of cardiovascular diseases during pregnancy: the Task Force on the management of cardiovascular diseases during pregnancy of the European Society of Cardiology. Eur Heart J. 2003; 24: 761-81. 6. Elkayam U. Pregnancy and cardiovascular disease. In: Zipes DP Libby P Bonow , , RO, Braunwald E. (editors). Braunwald’s heart disease: a textbook of cardiovascular medicine. 7th ed. Philadelphia: WB Saunders; 2004. p. 1965-84. 7. Ro A, Frishman WH. Peripartum cardiomyopathy. Cardiol Rev. 2006; 14: 35-42. 8. Pearson GD, Veille JC, Rahimtoola S, Hsia J, Oakley CM, Hosenpud JD, et al. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases Workshop Recommendations and Review. JAMA. 2000; 283: 1183-8. 9. Elkayam U, Akhter MW, Singh H, Khan S, Bitar F, Hameed A, et al. Pregnancy: associated cardiomyopathy. Circulation. 2005; 111: 2050-5. 10. Reimold SC, Rutherford JD. Peripartum cardiomyopathy. N Engl J Med. 2001; 344: 1629-30. 11. Sliwa K, Fett J, Elkayam U. Peripartum cardiomyopathy. Lancet. 2006; 368: 687-93. 12. Hilfiker-Kleiner D, Kaminski K, Podewski E, Bonda T, Schaefer A, Sliwa K, et al. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell. 2007; 128: 589-600. 13. Lang RM, Lampert MB, Poppas A, Hameed A, Elkayam U. Peripartal cardiomyopathy. In: Elkayam U, Gleicher N. (editors). Cardiac problems in pregnancy. 3rd ed. New York: Wiley-Liss; 1998. p. 87-100. 14. Fett JD. Inflammation and virus in dilated cardiomyopathy as indicated by endomyocardial biopsy. Int J Cardiol. 2006; 112: 125-6. 15. Nabhan A. Peripartum cardiomiopathy. ASJOG. 2005; 2 (1): 231-7. 16. Kleiner DH, Meyer GP Schieffer E, Goldmann B, Podewski E, Struman I, et al. , Recovery from postpartum cardiomyopathy in two patients by blocking prolactin release with bromocriptine. J Am